Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $31.12 Consensus PT from Analysts
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) have been assigned a consensus recommendation of “Moderate ...
Palvella Therapeutics (NASDAQ:PVLA) Now Covered by TD Cowen
TD Cowen began coverage on shares of Palvella Therapeutics (NASDAQ:PVLA – Free Report) in a research report released on Wednesday morning, MarketBeat.com reports. The firm issued a buy rating and a ...
Amgen: Multiple Strengths, But The Valuation Is A Concern
Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...